Allergy Therapeutics PLC Stock
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Allergy Therapeutics PLC | -4.350% | -2.941% | 22.222% | -30.526% | 53.488% | -86.694% | - |
Alliance Pharma plc | 2.150% | -7.317% | -6.863% | -50.649% | -5.941% | -65.455% | - |
Beximco Pharmaceuticals Ltd. GDR | - | -11.020% | -3.111% | 3.810% | -0.909% | -52.865% | -22.143% |
Cellectar BioSciences Inc. | -0.660% | 2.817% | 1.389% | 95.973% | 28.070% | -72.963% | - |
News
Will AT&T Increase Its Dividend This Year?
Before the pandemic disrupted its operations, AT&T (NYSE: T) was a reliable dividend stock. Not only that, but it was also a dividend-growth stock. For decades, the company increased dividend
Why AST SpaceMobile Stock Is Up Again Today
A day after AST SpaceMobile (NASDAQ: ASTS) stock got a big boost from the company solidifying a key partnership, Wall Street is rallying to the cause. Shares of the space communications company got
Why AST SpaceMobile Stock Is Blasting Off Today
Space mobility specialist AST SpaceMobile (NASDAQ: ASTS) is formalizing ties with partner AT&T ahead of its commercial launch this summer. That news, along with AST's latest earnings report, has the